Hyperlipidaemia 3Ed PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Hyperlipidaemia 3Ed PDF full book. Access full book title Hyperlipidaemia 3Ed by Paul Durrington. Download full books in PDF and EPUB format.
Author: Paul Durrington
Publisher: CRC Press
ISBN: 0340807814
Category : Medical
Languages : en
Pages : 429
Get Book Here
Book Description
The third edition of this well-received text provides a state-of-the-art treatise on modern clinical practice relating to hyperlipidaemia and lipoprotein disorders, conditions responsible for a huge amount of morbidity and mortality in Western countries and, increasingly, the developing world. The clinical evidence underlying the treatment of hyperlipidaemia has burgeoned since the second edition published in 1994, with the publication of the results of several clinical trials on statin drugs, and the subsequent appearance of national and international guidelines for cholesterol lowering in coronary prevention. There has also been considerable development in the definition of cardiovascular risk, and the methodology for identifying high-risk patients. All of these aspects are addressed fully in the new edition. In addition, the book offers helpful summaries of the background biochemistry of lipoprotein metabolism and atherosclerosis where relevant, putting the subject in the context of its pathophysiology and epidemiology. The text relating to clinical aspects has a strong evidence base, reviewing, in particular, areas of uncertainty and controversy. Drawing on the wealth of experience of the author, and representing his widely respected views on the subject, readers will find this comprehensive, well-referenced and accessible book invaluable.
Author: Paul Durrington
Publisher: CRC Press
ISBN: 0340807814
Category : Medical
Languages : en
Pages : 429
Get Book Here
Book Description
The third edition of this well-received text provides a state-of-the-art treatise on modern clinical practice relating to hyperlipidaemia and lipoprotein disorders, conditions responsible for a huge amount of morbidity and mortality in Western countries and, increasingly, the developing world. The clinical evidence underlying the treatment of hyperlipidaemia has burgeoned since the second edition published in 1994, with the publication of the results of several clinical trials on statin drugs, and the subsequent appearance of national and international guidelines for cholesterol lowering in coronary prevention. There has also been considerable development in the definition of cardiovascular risk, and the methodology for identifying high-risk patients. All of these aspects are addressed fully in the new edition. In addition, the book offers helpful summaries of the background biochemistry of lipoprotein metabolism and atherosclerosis where relevant, putting the subject in the context of its pathophysiology and epidemiology. The text relating to clinical aspects has a strong evidence base, reviewing, in particular, areas of uncertainty and controversy. Drawing on the wealth of experience of the author, and representing his widely respected views on the subject, readers will find this comprehensive, well-referenced and accessible book invaluable.
Author: Nicholas Procter
Publisher: Cambridge University Press
ISBN: 1108984622
Category : Medical
Languages : en
Pages : 509
Get Book Here
Book Description
Mental Health equips students with the tools to provide person-focused care when supporting improved mental health of diverse communities.
Author: Christophe Wiart
Publisher: CRC Press
ISBN: 1351711334
Category : Medical
Languages : en
Pages : 563
Get Book Here
Book Description
Medicinal Plants in Asia for Metabolic Syndrome: Natural Products and Molecular Basis offers an in-depth view into the metabolic syndrome pharmacology of natural products with an emphasis on their molecular basis, cellular pathways, metabolic organs, and endocrine regulations. This sensational volume provides the scientific names, botanical classifications, botanical descriptions, medicinal uses, chemical constituents, and pharmacological activities of more than 100 Asian plants, with high quality original botanical plates, chemical structures, and pharmacological diagrams. It also lists hundreds of carefully selected bibliographical references, constituents on insulin resistance, obesity, atherosclerosis, atherogenic dyslipidemia, and endothelial dysfunction.
Author: David Ames
Publisher: CRC Press
ISBN: 1444114611
Category : Medical
Languages : en
Pages : 856
Get Book Here
Book Description
The rising prevalence of dementia in the population continues to pose a serious public health challenge in both the developed and the developing world. Previous editions of Dementia have become acknowledged as a key 'gold standard' work in this field, and have had a genuinely international approach. The third edition has been fully revised and upda
Author: Christie M. Ballantyne
Publisher: Elsevier Health Sciences
ISBN: 1416054693
Category : Medical
Languages : en
Pages : 605
Get Book Here
Book Description
Clinical Lipidology, a companion to Braunwald's Heart Disease, is designed to guide you through the ever-changing therapeutic management of patients with high cholesterol levels. From basic science to pathogenesis of atherothrombotic disease, to risk assessment and the latest therapy options, this medical reference book offers unparalleled coverage and expert guidance on lipidology in a straightforward, accessible, and user-friendly style. Get authoritative guidance from some of the foremost experts in the field. Easily access key content with help from treatment algorithms. Access options and evidence-based solutions for every type of patient scenario, as well as the latest clinical guidelines and clinically relevant evidence on risk assessment, special patient populations, and therapy, including recently approved and experimental therapies. Remain at the forefront of the cardiology field with up-to-date chapters on treatment guidelines; diet, exercise, and weight loss; pharmacologic therapies such as statins, omega-3 fatty acids, and combination therapy; evolving targets of therapy such as PCSK9 inhibition, CETP inhibition, and inflammation Prepare for special patient populations such as children and adolescents; women and the elderly; transplant recipients; HIV patients; and those with chronic renal disease, familial hypercholesterolemia, other severe hypercholesterolemias, diabetes, or other metabolic syndromes. Take advantage of a format that follows that of the well-known and internationally recognized Braunwald's Heart Disease. Expert Consult eBook version included with purchase.
Author: Christie M. Ballantyne
Publisher: Elsevier Health Sciences
ISBN: 1437711235
Category : Medical
Languages : en
Pages : 605
Get Book Here
Book Description
Dr. Ballantyne—one of the foremost lipid experts in the world and recruited by Dr. Braunwald’s Heart Disease editorial team—together with a stellar cast of contributors provides all of the scientific and clinical information you need to effectively manage every aspect of dyslipidemia. From basic science to pathogenesis of atherothrombotic disease to risk assessment and the latest therapy options, this new title in the Braunwald’s Heart Disease family offers unparalleled coverage and expert guidance on lipidology in a straightforward, accessible, and user-friendly style. • Features the expertise of one of the foremost experts in the field, ensuring you get authoritative guidance with the most definitive knowledge available. • Contains extensive clinically relevant information covering risk assessment, therapy, special patient populations, and experimental therapies, including targeting HDL to help you effectively manage any challenges you face. • Uses treatment algorithms for easy access to key content. • Presents current practice guidelines that assist in the decision-making process.
Author: Tapan Ghose
Publisher: JP Medical Ltd
ISBN: 9352501950
Category : Medical
Languages : en
Pages : 269
Get Book Here
Book Description
Handbook of Lipidology is a practical guide to the basics of, clinical approach to, and therapeutic options for different lipid disorders. The book is divided into twenty one chapters, covering different aspects of lipid disorders, ranging from dyslipidaemia and atherosclerosis, to obesity and hyperlipidaedmia. The first chapter covers the history of dyslipidaemia research, followed by a chapter on epidemiology of lipid disorders. Other chapters cover topics such as lifestyle modifications for the management of dyslipidaemia, diet, weight loss, and kidney disease. Enhanced by full colour images and information tables throughout, Handbook of Lipidology is an ideal reference guide for busy clinicians and postgraduates. Key Points Practical guide to the management of lipid disorders Includes history, molecular biology, medication and management of various disorders Images and illustrations throughout
Author:
Publisher: Academic Press
ISBN: 0128122005
Category : Medical
Languages : en
Pages : 4225
Get Book Here
Book Description
Encyclopedia of Endocrine Diseases, Second Edition, Five Volume Set comprehensively reviews the extensive spectrum of diseases and disorders that can occur within the endocrine system. It serves as a useful and comprehensive source of information spanning the many and varied aspects of the endocrine end metabolic system. Students will find a concise description of the physiology and pathophysiology of endocrine and metabolic functions, as well as their diseases. Each article provides a comprehensive overview of the selected topic to inform a broad spectrum of readers, from advanced undergraduate students, to research professionals. Chapters explore the latest advances and hot topics that have emerged in recent years, such as the molecular basis of endocrine and metabolic diseases (mutations, epigenetics, signaling), the pathogenesis and therapy of common endocrine diseases (e.g. diabetes and endocrine malignancies), new technologies in endocrine research, new methods of treatment, and endocrine toxicology/disruptors. Covers all aspects of endocrinology and metabolism Incorporates perspectives from experts working within the domains of biomedicine (e.g. physiology, pharmacology and toxicology, immunology, genetics) and clinical sciences to provide readers with reputable, multi-disciplinary content from domain experts Provides a ‘one-stop’ resource for access to information as written by world-leading scholars in the field, with easy cross-referencing of related articles to promote understanding and further research
Author: Miles Levy
Publisher: Remedica
ISBN: 1901346390
Category : Diagnosis, Differential
Languages : en
Pages : 129
Get Book Here
Book Description
This book is not designed to be easy reading. It is simply a catalogue of lists that have been amalgamated by previous MRCP candidates who have sat the Part 1 and Part 2 examinations. The lists, or 'chestnuts', contain the most important differential diagnoses that are relevant to clinical practice and the MRCP exam. The lists will enable you to create useful differential diagnoses on the spot. As the format of the MRCP examination is constantly under review, it is hoped that these lists will provide a concise and portable text, which will be continually relevant to the examination, as well as clinical medicine.
Author: Martin R. Wilkins
Publisher: Springer Science & Business Media
ISBN: 3662062143
Category : Medical
Languages : en
Pages : 424
Get Book Here
Book Description
The Human Genome Project was sold to the general public largely on the basis that a complete picture of the structure of human DNA would lead to new and better medicines. These medicines would be better because they would be tailored to individual patients, maximising the chances of a therapeutic response and mi nimising the risks of an adverse event. Taking the idea further, pundits have pre dicted that the time will come when we could carry our DNA on a card which could be read rapidly and enable the physician to choose the best drug. This is the future. This is pharmacogenetics. When the draft human DNA sequence was announced and scientists were as ked how this would help drug development, the example most frequently given was the debrisoquine model - where poor metabolisers of this hypotensive agent are exposed to higher plasma levels from a standard dose and at risk of collapse from excessive hypotension. This observation was made over 20 years ago and predated designs to sequence the human genome. Nonetheless, it raised aware ness of variation in drug metabolism and was correctly assigned to genetic poly morphisms affecting CYP2D6. Together with the discovery of pseudocholinestera se deficiency, it marked the birth of pharmacogenetics. The debrisoquine example is an interesting one and worthy of further analysis.
